Chang-Gong Liu Selected Research

MicroRNAs (MicroRNA)

1/2018	Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer.
1/2017	A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks.
5/2016	Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer.
4/2016	MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.
7/2015	The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model.
1/2015	Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions.
10/2014	Regulation of the extrinsic apoptotic pathway by microRNA-21 in alcoholic liver injury.
1/2014	MicroRNA profiles discriminate among colon cancer metastasis.
11/2013	Plasma microRNA profiles for bladder cancer detection.
9/2013	miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chang-Gong Liu Research Topics

Disease

65	Neoplasms (Cancer) 01/2022 - 01/2002
11	Breast Neoplasms (Breast Cancer) 01/2018 - 08/2005
10	Carcinogenesis 01/2014 - 09/2005
7	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2006
6	Lung Neoplasms (Lung Cancer) 10/2018 - 03/2006
6	Adenocarcinoma 01/2018 - 01/2002
6	Carcinoma (Carcinomatosis) 01/2015 - 09/2005
6	Leukemia 05/2010 - 08/2004
5	Prostatic Neoplasms (Prostate Cancer) 04/2015 - 08/2008
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2011 - 03/2008
4	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 09/2007
4	Hepatocellular Carcinoma (Hepatoma) 05/2011 - 07/2007
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2009 - 08/2004
3	Inflammatory Breast Neoplasms 01/2018 - 04/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 05/2007
3	Heart Failure 01/2017 - 10/2009
3	Chromosome Aberrations (Chromosome Abnormalities) 02/2013 - 05/2007
3	Esophageal Neoplasms (Esophageal Cancer) 10/2009 - 09/2005
3	Ovarian Epithelial Carcinoma 12/2008 - 09/2007
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 05/2016
2	Colitis 10/2018 - 12/2011
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 10/2014 - 09/2012
2	Colonic Neoplasms (Colon Cancer) 01/2014 - 01/2008
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2013 - 10/2009
2	Hypoxia (Hypoxemia) 05/2013 - 03/2007
2	Endometrial Neoplasms (Endometrial Cancer) 11/2012 - 06/2010
2	Stomach Neoplasms (Stomach Cancer) 05/2012 - 03/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2012 - 04/2009
2	Liver Neoplasms (Liver Cancer) 01/2012 - 07/2008
2	Myeloid Leukemia (Leukemia, Myelocytic) 10/2011 - 03/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2009 - 01/2002
2	Infections 09/2008 - 12/2005
2	Retinoblastoma (Glioblastoma, Retinal) 02/2006 - 01/2005
1	Triple Negative Breast Neoplasms 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 07/2015
1	Costello Syndrome 07/2015
1	Prostatic Intraepithelial Neoplasia 04/2015
1	Pancreatic Cyst 01/2015
1	Brain Neoplasms (Brain Tumor) 05/2014
1	Colorectal Neoplasms (Colorectal Cancer) 01/2014
1	Non-Muscle Invasive Bladder Neoplasms 11/2013

Drug/Important Bio-Agent (IBA)

61	MicroRNAs (MicroRNA)IBA 01/2018 - 06/2004
20	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2002
12	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2005
7	Pharmaceutical PreparationsIBA 01/2018 - 05/2007
7	Messenger RNA (mRNA)IBA 04/2016 - 05/2007
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2005
6	Biological ProductsIBA 04/2011 - 08/2004
5	RNA (Ribonucleic Acid)IBA 02/2013 - 05/2007
2	Ligases (Synthetase)IBA 01/2021 - 04/2009
2	CytokinesIBA 01/2021 - 10/2009
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 05/2013
2	NucleotidesIBA 01/2015 - 03/2008
2	Tamoxifen FDA LinkGeneric 09/2013 - 01/2012
2	Estrogens (Estrogen)FDA Link 09/2013 - 08/2005
2	Decitabine FDA Link 02/2013 - 09/2007
2	Histone Deacetylase InhibitorsIBA 02/2013 - 07/2008
2	trichostatin A (A 300)IBA 02/2013 - 07/2008
2	Small Interfering RNA (siRNA)IBA 11/2012 - 05/2010
2	Calcitriol (Calcijex)FDA LinkGeneric 10/2011 - 03/2009
2	1,25-dihydroxyvitamin DIBA 10/2011 - 03/2009
2	ZincIBA 03/2009 - 09/2005
2	MetallothioneinIBA 08/2008 - 09/2005
2	NucleophosminIBA 05/2008 - 03/2008
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	SaltsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Dextrans (Dextran)FDA Link 10/2018
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2018
1	taxaneIBA 01/2018
1	LigandsIBA 01/2018
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2018
1	angiogeninIBA 01/2018
1	Competitive Endogenous RNAIBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	AnthracyclinesIBA 01/2018
1	Ribonucleases (Ribonuclease)IBA 01/2018
1	Zinc Finger E-box-Binding Homeobox 1IBA 01/2018
1	IACS-010759IBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	Untranslated RNA (Noncoding RNA)IBA 01/2017
1	AntibodiesIBA 01/2017
1	Transfer RNA (tRNA)IBA 01/2017
1	Cadherins (E-Cadherin)IBA 04/2016
1	ras ProteinsIBA 07/2015
1	LuciferasesIBA 04/2015
1	Bortezomib (Velcade)FDA Link 04/2015
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 04/2015
1	Sirtuin 3IBA 09/2013
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 09/2013

Therapy/Procedure

16	Therapeutics 01/2022 - 09/2005
4	Drug Therapy (Chemotherapy) 01/2022 - 05/2007
2	Radiotherapy 01/2018 - 01/2017
2	Immunotherapy 01/2018 - 05/2010
1	Neoadjuvant Therapy 01/2018